The reports indicated PSMD1 promotes NF‐κB protein stability and transcriptional activity in chronic myeloid leukaemia and modulates the degradation of the p53 protein, which contribute to the proliferation of breast cancer cells.24, 42. This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.